The Latest Breaking News from Asia

Lex in depth: why the luxury market needs to hedge against China

A shift in spending habits in Asia and a crackdown on wealth by Beijing threaten a profit squeeze for high-end brands

Financial Times · May 8, 2022

Southeast Asia stock markets stand out as geopolitical heaven for investors

Fed hikes, decades-high inflation and Covid lockdowns in China are only adding to investor bets that Southeast Asia’s stock markets may be one of the best places to park their money right now.

Bangkok Post · May 8, 2022

From India’s highs to Thailand’s lows, Asia’s weather is hitting extremes

Analysis: As the heatwave in India and Pakistan starts to intensify again, Thailand and China are recording strangely cold May days

The Guardian - UK · May 7, 2022

Japan’s path to becoming a leader in Western science: an Asian perspective on science and other forms of knowledge

Several well-intentioned efforts seek to incorporate mātauranga Māori (Māori knowledge) into science in New Zealand. These include a pilot National Certificate in Educational Achievement (NCEA) programme in biology and chemistry which places mātauranga Māori concepts on an equal footing with science. Other proposals aim to do the same for university…

The Conversation · May 6, 2022

AP Week in Pictures: Asia

April 29-May 5, 2022

The Independent UK · May 6, 2022

The Trouble With “the Free World”

Why It’s a Bad Idea to Revive a Cold War Concept

Foreign Affairs · May 6, 2022

Aptiv Q1 Earnings Top Estimates

Aptiv PLC (NYSE:APTV) reported first-quarter FY22 sales growth of 4% year-on-year to $4.18 billion, beating the consensus of $4.04 billion. Revenue rose 4% adjusted for currency exchange and commodity movements. Revenue in North America rose 7%, South America increased 24%, Europe fell 5%, and Asia increased 9%, which includes growth of 14% in…

Benzinga · May 5, 2022

Japanese premier warns of Ukraine-style invasion by ‘autocratic powers’

Kishida also promised increased reliance upon nuclear power for future energy independence

The Guardian - UK · May 5, 2022

Ingredion Clocks 17% Top-Line Growth Amid Inflationary Pressures

Ingredion Inc (NYSE:INGR) reported first-quarter FY22 sales growth of 17% year-on-year to $1.89 billion, beating the consensus of $1.77 billion. Sales in North America increased 24% Y/Y to $1.2 billion, South America fell 8% to $252 million, Asia-Pacific grew 16% to $272 million, and EMEA climbed 20% to $194 million. The gross profit…

Benzinga · May 5, 2022

Jazz Pharma, Sumitomo Pharma Ink Licensing Pact For Sleeping Disorder Candidate

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has acquired development and commercialization rights in the U.S., Europe, and other territories for Sumitomo Pharma's investigational DSP-0187. DSP-0187 is a potent, highly selective oral orexin-2 receptor agonist with potential application for treating narcolepsy, idiopathic hypersomnia, and other sleep disorders.  Jazz has designated this molecule JZP441. Sumitomo Pharma initiated a Phase…

Benzinga · May 5, 2022